BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen Z, Li B, Liu Y, Zheng G, Guo Y, Zhao R, Jiang K, Fan L, Shao J. A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy. Nanomedicine 2018;14:227-36. [PMID: 29128661 DOI: 10.1016/j.nano.2017.10.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Yu S, Wen R, Wang H, Zha Y, Qiu L, Li B, Xue W, Ma D. Chitosan- graft -Poly( l -lysine) Dendron-Assisted Facile Self-Assembly of Au Nanoclusters for Enhanced X-ray Computer Tomography Imaging and Precise MMP-9 Plasmid shRNA Delivery. Chem Mater 2019;31:3992-4007. [DOI: 10.1021/acs.chemmater.9b00507] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
2 Pan X, Liu S, Ju L, Xi J, He R, Zhao Y, Zhuang R, Huang J. Preparation, evaluation, and in vitro cytotoxicity studies of artesunate-loaded glycyrrhetinic acid decorated PEG-PLGA nanoparticles. Drug Dev Ind Pharm 2020;46:1889-97. [PMID: 32975456 DOI: 10.1080/03639045.2020.1825475] [Reference Citation Analysis]
3 Fan Y, Liu Y, Wu Y, Dai F, Yuan M, Wang F, Bai Y, Deng H. Natural polysaccharides based self-assembled nanoparticles for biomedical applications - A review. Int J Biol Macromol 2021;192:1240-55. [PMID: 34678381 DOI: 10.1016/j.ijbiomac.2021.10.074] [Reference Citation Analysis]
4 Zhao RR, Fang YF, Chen ZX, Le JQ, Jiang LG, Shao JW. Self-assembled amphiphile-based nanoparticles for the inhibition of hepatocellular carcinoma metastasis via ICAM-1 mediated cell adhesion. Acta Biomater 2020;111:373-85. [PMID: 32413580 DOI: 10.1016/j.actbio.2020.04.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ma Z, Zhang B, Fan Y, Wang M, Kebebe D, Li J, Liu Z. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomed Pharmacother 2019;117:109128. [PMID: 31234023 DOI: 10.1016/j.biopha.2019.109128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
6 Hussain A, Rehman F, Rafeeq H, Waqas M, Asghar A, Afsheen N, Rahdar A, Bilal M, Iqbal HMN. In-situ, Ex-situ, and nano-remediation strategies to treat polluted soil, water, and air - A review. Chemosphere 2022;289:133252. [PMID: 34902385 DOI: 10.1016/j.chemosphere.2021.133252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
7 Gulla SK, Kotcherlakota R, Nimushakavi S, Nimmu NV, Khalid S, Patra CR, Chaudhuri A. Au-CGKRK Nanoconjugates for Combating Cancer through T-Cell-Driven Therapeutic RNA Interference. ACS Omega 2018;3:8663-76. [PMID: 31458997 DOI: 10.1021/acsomega.8b01051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Fu D, Ni Z, Wu K, Cheng P, Ji X, Li G, Shang X. A novel redox-responsive ursolic acid polymeric prodrug delivery system for osteosarcoma therapy. Drug Deliv 2021;28:195-205. [PMID: 33438472 DOI: 10.1080/10717544.2020.1870583] [Reference Citation Analysis]
9 Yang Y, Wang C, Wei M. Validation of a greener procedure for the extraction of triterpenic acids from Hedyotis corymbosa. Microchemical Journal 2021;165:106062. [DOI: 10.1016/j.microc.2021.106062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gong X, Zheng Y, He G, Chen K, Zeng X, Chen Z. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy. Drug Deliv 2019;26:595-603. [PMID: 31195837 DOI: 10.1080/10717544.2019.1625467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shen JW, Li C, Yang MY, Lin JF, Yin MD, Zou JJ, Wu PY, Chen L, Song LX, Shao JW. Biomimetic nanoparticles: U937 cell membranes based core-shell nanosystems for targeted atherosclerosis therapy. Int J Pharm 2022;611:121297. [PMID: 34822966 DOI: 10.1016/j.ijpharm.2021.121297] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhou M, Yi Y, Liu L, Lin Y, Li J, Ruan J, Zhong Z. Polymeric micelles loading with ursolic acid enhancing anti-tumor effect on hepatocellular carcinoma. J Cancer 2019;10:5820-31. [PMID: 31737119 DOI: 10.7150/jca.30865] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
13 Ma J, Chen Y, Liang W, Li L, Du J, Pan C, Zhang C. ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer. Drug Deliv 2021;28:1204-13. [PMID: 34142633 DOI: 10.1080/10717544.2021.1937380] [Reference Citation Analysis]
14 Alonso S. Exploiting the bioengineering versatility of lactobionic acid in targeted nanosystems and biomaterials. Journal of Controlled Release 2018;287:216-34. [DOI: 10.1016/j.jconrel.2018.08.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
15 Shao J, Fang Y, Zhao R, Chen F, Yang M, Jiang J, Chen Z, Yuan X, Jia L. Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid. Asian J Pharm Sci 2020;15:685-700. [PMID: 33363625 DOI: 10.1016/j.ajps.2020.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
16 Zou J, Lin J, Li C, Zhao R, Fan L, Yu J, Shao J. Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies. CCDT 2019;19:245-56. [DOI: 10.2174/1568009618666181016145940] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Li B, Wang F, Gui L, He Q, Yao Y, Chen H. The potential of biomimetic nanoparticles for tumor-targeted drug delivery. Nanomedicine 2018;13:2099-118. [DOI: 10.2217/nnm-2018-0017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
18 Zhang B, Wu P, Zou J, Jiang J, Zhao R, Luo B, Liao Y, Shao J. Efficient CRISPR/Cas9 gene-chemo synergistic cancer therapy via a stimuli-responsive chitosan-based nanocomplex elicits anti-tumorigenic pathway effect. Chemical Engineering Journal 2020;393:124688. [DOI: 10.1016/j.cej.2020.124688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
19 Kaps A, Gwiazdoń P, Chodurek E. Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies. Molecules 2021;26:1764. [PMID: 33801096 DOI: 10.3390/molecules26061764] [Reference Citation Analysis]
20 Lin JF, Fan LL, Li BW, Zhao RR, Jiang LG, Zhang BC, Lu YS, Shao JW. A study to evaluate herb-drug interaction underlying mechanisms: An investigation of ginsenosides attenuating the effect of warfarin on cardiovascular diseases. Eur J Pharm Sci 2020;142:105100. [PMID: 31669385 DOI: 10.1016/j.ejps.2019.105100] [Reference Citation Analysis]
21 Alfei S, Schito AM, Zuccari G. Considerable Improvement of Ursolic Acid Water Solubility by Its Encapsulation in Dendrimer Nanoparticles: Design, Synthesis and Physicochemical Characterization. Nanomaterials (Basel) 2021;11:2196. [PMID: 34578512 DOI: 10.3390/nano11092196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang B, Jiang J, Wu P, Zou J, Le J, Lin J, Li C, Luo B, Zhang Y, Huang R, Shao J. A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy. Acta Pharm Sin B 2021;11:246-57. [PMID: 33532190 DOI: 10.1016/j.apsb.2020.07.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Miatmoko A, Mianing EA, Sari R, Hendradi E. Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review. Front Pharmacol 2021;12:787226. [PMID: 35002719 DOI: 10.3389/fphar.2021.787226] [Reference Citation Analysis]